Table 5.
PP | SP | |||||||
---|---|---|---|---|---|---|---|---|
All SP | TSM | DP | ||||||
Sample Size | ||||||||
Patients, n* | 405+ | 408+ | 95+ | 313 | ||||
Breasts, n | 860+ | 1038 | 512 | 526 | ||||
Factor | Value | N Reporting | Value | N Reporting | Value | N Reporting | Value | N Reporting |
Age, mean (y) | 46.4 | 405 | 47.4 | 408 | 44 | 95 | 47.1 | 313 |
BMI, mean | 24.4 | 405 | 24.3 | 408 | 24.8 | 95 | 24.2 | 313 |
Diabetes, % (n) | 5.3 (11) | 207 | 3.5 (7) | 199 | NR | 0 | 3.5 (7) | 199 |
Tobacco use, % (n) | 2.2 (7) | 323 | 6.7 (21) | 313 | NR | 0 | 6.7 (21) | 313 |
XRT, preoperative, % (n) | 2.3 (13) | 571 | 1.6 (8) | 486 | 0 (0) | 146 | 2.4 (8) | 340 |
XRT, adjuvant, % (n) | 11.3 (51) | 452 | 10.9 (51) | 470 | 15.1 (22) | 146 | 9.0 (29) | 324 |
Mastectomy weight, mean (g) | 372.4 | 272 | 356.3 | 198 | NR | 0 | 356.3 | 198 |
Implant size, mean (mL) | 442.4 | 323 | 434.5 | 313 | NR | 0 | 434.5 | 313 |
ADM use, % (n) | 75.1 (492) | 655 | 48.5 (1038) | 672 | 0 | 512† | 96.0 (503) | 526 |
Diagnosis | 209 | 79 | 0 | 79 | ||||
Prophylactic, % (n) | 62.2 (130) | 59.5 (47) | NR | 59.5 (47) | ||||
Cancer, % (n) | 37.8 (79) | 40.5 (32) | NR | 40.5 (32) | ||||
Staged | 860 | 1038 | 512 | 526 | ||||
TE, % (n) | 41.9 (360) | 58.0 (602) | 41.6 (213) | 74.0 (389) | ||||
DTI, % (n) | 57.4 (494) | 41.6 (432) | 58.4 (299) | 25.3 (133) | ||||
Implant Type | 312 | 348 | 146 | 202 | ||||
Smooth, % (n) | 52.6 (164) | 22.4 (78) | 0 (0) | 38.6 (78) | ||||
Textured, % (n) | 46.2 (144) | 69.3 (241) | 100 (146) | 47.1 (95) | ||||
Mastectomy Incision | 412 | 281 | 0 | 281 | ||||
Radial, % (n) | 17.2 (71) | 3.9 (11) | NR | 8.9 (25) | ||||
IMF, % (n) | 79.1 (326) | 85.4 (240) | NR | 85.4 (240) | ||||
Wise pattern, % (n) | 1.0 (4) | 0 | NR | 0 | ||||
Periareolar, % (n) | 0 | 0 | NR | 0 |
Sample size (patients) was not reported by all studies. NR, not reported.
All TSM reconstructions were assumed to be performed without ADM if not specified.